Von Hippel-Lindau Peptide Vaccine

**Semantic type:** Chemical Viewed Functionally

**Definition:** A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. (NCI04)

**Synonyms:** - VHL Peptides - VHL peptide vaccine